MSD is unified in one purpose: to use the power of leading-edge science to save and improve lives around the world. For more ...

GAITHERSBURG, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial ...

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial Officer ...

SAN FRANCISCO--(BUSINESS WIRE)--Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today ...

Mars' global magnetic field may have hung around for 200 million years longer than scientists had thought, possibly giving ...

Lifeward, a Marlborough-based mobility device manufacturer, has expanded its board of directors, naming Robert Marshall as its newest member.

Winners received prestigious award in recognition of latest innovations in advancement in life sciences ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Intel Corporation, one of the world's largest semiconductor designers and manufacturers, have begun the implementation of ...

The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.